Evaluation of early second trimester maternal serum creatine kinase isoenzyme BB as a marker of poor pregnancy outcome

Fetal Diagn Ther. 1997 Nov-Dec;12(6):356-9. doi: 10.1159/000264505.

Abstract

We hypothesized that maternal serum levels of the isoenzyme creatine kinase (CK)-BB, which is highly expressed in the placenta, may be elevated during the early second trimester in gestations destined to deliver prematurely or of a small-for-gestational-age infant (birthweight below 10th percentile). To test this hypothesis, we compared maternal serum CK-BB levels and percentage of CK-BB over total CK, in 69 normal pregnancies (delivering at term of appropriate-for-gestational-age infants) with those of 25 cases complicated by preterm delivery at < or = 34 weeks (n = 14), of a small-for-gestational-age infant (n = 8), or both (n = 3). No differences were present in maternal serum CK BB levels between normal and complicated pregnancies. Moreover, no correlation was found between gestational age at delivery and CK BB levels (r = 0.03; p = 0.7).

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Biomarkers / blood
  • Cohort Studies
  • Creatine Kinase / blood*
  • Female
  • Gestational Age
  • Humans
  • Isoenzymes
  • Pregnancy
  • Pregnancy Complications / blood
  • Pregnancy Complications / diagnosis*
  • Pregnancy Complications / enzymology
  • Pregnancy Outcome*
  • Pregnancy Trimester, Second

Substances

  • Biomarkers
  • Isoenzymes
  • Creatine Kinase